156 related articles for article (PubMed ID: 27153463)
1. Nuclear factor XIIIa staining (clone AC-1A1 mouse monoclonal) is a highly sensitive marker of sebaceous differentiation in normal and neoplastic sebocytes.
Clark LN; Elwood HR; Uhlenhake EE; Smoller BR; Shalin SC; Gardner JM
J Cutan Pathol; 2016 Aug; 43(8):657-62. PubMed ID: 27153463
[TBL] [Abstract][Full Text] [Related]
2. Nuclear factor XIIIa staining (clone AC-1A1 mouse monoclonal) is a sensitive and specific marker to discriminate sebaceous proliferations from other cutaneous clear cell neoplasms.
Uhlenhake EE; Clark LN; Smoller BR; Shalin SC; Gardner JM
J Cutan Pathol; 2016 Aug; 43(8):649-56. PubMed ID: 27153339
[TBL] [Abstract][Full Text] [Related]
3. Evaluation and comparison of staining patterns of factor XIIIa (AC-1A1), adipophilin and GATA3 in sebaceous neoplasia.
Tjarks BJ; Pownell BR; Evans C; Thompson PA; Kerkvliet AM; Koch MRD; Jassim AD
J Cutan Pathol; 2018 Jan; 45(1):1-7. PubMed ID: 28873247
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of D2-40 in benign and malignant sebaceous tumors and comparison to basal and squamous cell carcinomas.
Yang HM; Cabral E; Dadras SS; Cassarino DS
Am J Dermatopathol; 2008 Dec; 30(6):549-54. PubMed ID: 19033927
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical staining for androgen receptors: a sensitive marker of sebaceous differentiation.
Bayer-Garner IB; Givens V; Smoller B
Am J Dermatopathol; 1999 Oct; 21(5):426-31. PubMed ID: 10535570
[TBL] [Abstract][Full Text] [Related]
6. Role of immunohistochemistry in the diagnosis of sebaceous carcinoma: a clinicopathologic and immunohistochemical study.
Plaza JA; Mackinnon A; Carrillo L; Prieto VG; Sangueza M; Suster S
Am J Dermatopathol; 2015 Nov; 37(11):809-21. PubMed ID: 26485238
[TBL] [Abstract][Full Text] [Related]
7. Expression of a glycoprotein of the carcinoembryonic antigen family in normal and neoplastic sebaceous glands. Limited role of carcinoembryonic antigen as a sweat gland marker.
Metze D; Soyer HP; Zelger B; Neumaier M; Grunert F; Hartig C; Amann U; Bhardwaj R; Wagener C; Luger T
J Am Acad Dermatol; 1996 May; 34(5 Pt 1):735-44. PubMed ID: 8632066
[TBL] [Abstract][Full Text] [Related]
8. Ocular Adnexal Adenomatoid Sebaceous Gland Hyperplasia: A Clinical and Immunopathologic Analysis in Relation to the Muir-Torre Syndrome.
Jakobiec FA; Cortes Barrantes P; Milman T; Lee NG; Fay A
Ophthalmic Plast Reconstr Surg; 2020; 36(1):e6-e12. PubMed ID: 31593035
[TBL] [Abstract][Full Text] [Related]
9. PRAME immunostain expression in sebaceous lesions, cutaneous carcinomas and adnexal structures.
Ng JKM; Choi PCL; Chow C; Li JJX; Chan AWS; Cheung CMT; Ip ECC; Ng HK; To KF
Pathology; 2022 Oct; 54(6):721-728. PubMed ID: 35644638
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratin 15 expression in neoplasms with sebaceous differentiation.
Misago N; Narisawa Y
J Cutan Pathol; 2006 Sep; 33(9):634-41. PubMed ID: 16965339
[TBL] [Abstract][Full Text] [Related]
11. Frequent TLE1 Expression in Cutaneous Neoplasms.
Xiong Y; Dresser K; Cornejo KM
Am J Dermatopathol; 2019 Jan; 41(1):1-6. PubMed ID: 30608261
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor expression in epidermal and adnexal tumours.
Bourlond F; Velter C; Cribier B
Ann Dermatol Venereol; 2021 Jun; 148(2):116-121. PubMed ID: 33478823
[TBL] [Abstract][Full Text] [Related]
13. [Differential diagnostics of sebaceous tumors].
Böer-Auer A
Pathologe; 2014 Sep; 35(5):443-55. PubMed ID: 25103328
[TBL] [Abstract][Full Text] [Related]
14. Distinction of benign sebaceous proliferations from sebaceous carcinomas by immunohistochemistry.
Cabral ES; Auerbach A; Killian JK; Barrett TL; Cassarino DS
Am J Dermatopathol; 2006 Dec; 28(6):465-71. PubMed ID: 17122489
[TBL] [Abstract][Full Text] [Related]
15. Expression of Malic Enzymes in Sebaceous Lesions.
Su TF; Gao HW
Am J Dermatopathol; 2016 Aug; 38(8):580-5. PubMed ID: 26381116
[TBL] [Abstract][Full Text] [Related]
16. Fordyce granules and hyperplastic mucosal sebaceous glands as distinctive stigmata in Muir-Torre syndrome patients: characterization with reflectance confocal microscopy.
Ponti G; Meschieri A; Pollio A; Ruini C; Manfredini M; Longo C; Mandel VD; Ciardo S; Tomasi A; Giannetti L; Pellacani G
J Oral Pathol Med; 2015 Aug; 44(7):552-7. PubMed ID: 25213213
[TBL] [Abstract][Full Text] [Related]
17. Immunolabeling pattern of cytokeratin 19 expression may distinguish sebaceous tumors from basal cell carcinomas.
Heyl J; Mehregan D
J Cutan Pathol; 2008 Jan; 35(1):40-5. PubMed ID: 18095993
[TBL] [Abstract][Full Text] [Related]
18. Perforin expression in eyelid sebaceous carcinomas: a useful and specific immunomarker for the differential diagnosis of eyelid carcinomas.
Mittal R; Araujo I; Czanner G; Coupland SE
Acta Ophthalmol; 2016 Aug; 94(5):e325-30. PubMed ID: 26843360
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of calretinin in normal skin and cutaneous adnexal proliferations.
González-Guerra E; Kutzner H; Rutten A; Requena L
Am J Dermatopathol; 2012 Jul; 34(5):491-505. PubMed ID: 22343111
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemistry screening of sebaceous lesions for Muir-Torre syndrome in a 26-year period in a Mexican population.
Archer-Dubon C; Alvarez-Zavala B; Reyes E; Orozco-Topete R
Dermatol Online J; 2008 Dec; 14(12):1. PubMed ID: 19265614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
